论文著作：
1. M. Zhang, H. Cai, Y. Du, Y. Wang, J. Gong#, J. Xu#, X. Liu#, Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination, Mol Pharm, 18 (2021) 1397-1407.
2. J. Liu, M. Zhang, Y. Kan, W. Wang, J. Liu, J. Gong#, J. Yang#, Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway, Frontiers in Cell and Developmental Biology, 8 (2021).
3. J. Gong, F. Guo, W. Cheng, H. Fan, Q. Miao, J. Yang, Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models, Artif Cells Nanomed Biotechnol, 48 (2020) 408-414.
4. J.H. Gong, Y.B. Zheng, M.R. Zhang, Y.X. Wang, S.Q. Yang, R.H. Wang, Q.F. Miao, X.J. Liu, Y.S. Zhen, Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling, Cancer Biol Ther, 21 (2020) 332-343.
5. X. Zhao, X. Qi, W. Lian, X. Tong, H. Wang, L. Su, P. Wei, Z. Zhuang, J. Gong#, L. Bai#, Trichomicin Suppresses Colorectal Cancer via Comprehensive Regulation of IL-6 and TNFalpha in Tumor Cells, TAMs, and CAFs, Front Pharmacol, 11 (2020) 386.
6. Y.B. Zheng#, J.H. Gong#, Y.S. Zhen, Focal adhesion kinase is activated by microtubule-depolymerizing agents and regulates membrane blebbing in human endothelial cells, J Cell Mol Med, 24 (2020) 7228-7238.
7. R. Wang, L. Li, A. Duan, Y. Li, X. Liu, Q. Miao#, J. Gong#, Y. Zhen, Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma, Cancer Lett, (2019).
8. J. Yang, F. Guo, L. Yuan, G. Lv, J. Gong#, J. Chen#, Elevated expression of the V-ATPase D2 subunit triggers increased energy metabolite levels in Kras(G12D) -driven cancer cells, J Cell Biochem, (2019).
9. C. Zhang, L.Y. Guo, D. Mu, J.H. Gong#, J. Chen#, Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin, Oncol Rep, 41 (2019) 475-482.
10. J. Gong, Y. Zheng, Y. Wang, W. Sheng, Y. Li, X. Liu, S. Si, R. Shao, Y. Zhen, A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway, PLoS One, 13 (2018) e0191984.
弓建华
北京市
研究领域：
生物医药
研究方向：
肿瘤免疫治疗药物研究；基于靶点发现的新型小分子抗肿瘤药物；抗体药物
所在单位：
中国医学科学院北京协和医学院
